Johnson & Johnson and its Janssen Pharmaceuticals affiliate were accused of specifically targeting elderly patients for opioid treatment despite the risks, and in marketing materials characterizing opioid addiction as a myth.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
